U.S. Banks Stock News

In recent months, Mirum Pharmaceuticals reported very large year-over-year net product revenue growth, reached GAAP profitability, raised full-year revenue guidance to about US$500 million, and secured multiple new approvals and trial milestones for its rare disease portfolio, including LIVMARLI and CTEXLI. This combination of improving financial performance and advancing late-stage studies, such as the EXPAND and VISTAS trials, is materially reshaping expectations for Mirum’s long-term rare...

WEC Energy Group’s Wisconsin utilities recently filed multi-year rate requests and delayed retirement of Oak Creek Power Plant units 7 and 8 through 2027 to support grid reliability and fund infrastructure and clean energy investments, while also advancing governance changes by proposing to remove supermajority voting requirements from its Articles of Incorporation and Bylaws. The company also received Federal Energy Regulatory Commission acknowledgement that its Sandstone Rapids...

Recent analyst activity around Smurfit Westrock (NYSE:SW), including maintained positive ratings, lower price targets, and new coverage from Goldman Sachs, has put the packaging group back in focus for investors. See our latest analysis for Smurfit Westrock. The recent pullback, including a 1 month share price return of an 8.31% decline and a year to date share price return of a 0.78% decline from about US$39.29, contrasts with a 3 year total shareholder return of 22.31% and suggests that...

In early April 2026, Avista Corporation proposed amending its Restated Articles of Incorporation to lower the shareholder approval threshold for certain matters from 80% of outstanding common shares to a simple majority. This shift toward a lower voting hurdle could reshape how quickly and easily major corporate decisions are authorized, potentially changing the balance of influence between management and shareholders. Next, we’ll examine how this move toward majority-based approvals...

In early April 2026, Houlihan Lokey reported third-quarter fiscal 2026 results that beat analyst expectations, with adjusted earnings per share of US$1.94 and revenue of US$717 million, driven largely by growth in its M&A and valuation advisory businesses even as restructuring activity softened. The company also disclosed a small insider sale by its General Counsel and a prospectus supplement for the potential resale of 32,421 shares tied to a prior acquisition, highlighting how dealmaking...

In recent days, Helix Energy Solutions Group reported fourth-quarter results with revenue slightly lower year on year but materially ahead of analyst expectations on EPS and EBITDA, while also securing a multi-year well plug and abandonment program in the UK North Sea. At the same time, rising crude prices amid heightened U.S.–Iran tensions have drawn attention to how geopolitical risk can influence demand for Helix’s offshore services and earnings potential. We’ll now examine how Helix’s...

In recent weeks, Melco Resorts & Entertainment reported mixed fourth-quarter 2025 results, while major banks including BofA Securities, UBS, and Morgan Stanley updated their research views on the company amid concerns over liquidity, margins, and Macau market conditions. At the same time, Melco underscored its premium positioning by highlighting eight MICHELIN Stars across five Macau restaurants, reinforcing how high-end non-gaming offerings are becoming a central part of its hospitality and...

Aflac (AFL) has drawn attention after Aflac Re Bermuda agreed to reinsure a block of whole life annuities from Japan Post Insurance through coinsurance, while also rolling out a new long term care focused life product. See our latest analysis for Aflac. Aflac’s recent reinsurance deal in Japan and new long term care life product in the U.S. come as the share price sits at US$110.48, with a 7 day share price return of 3.82% but a slightly negative 90 day share price return, while longer term...

In the past quarter, Ingersoll Rand reported revenues of US$2.09 billion, a 10.1% year-on-year increase that exceeded analyst expectations by 2.6%, alongside stronger earnings and free cash flow in what management called a complex global backdrop. At the same time, insider sentiment turned more cautious with increased insider selling, even as Barclays reaffirmed its positive view on the company’s operational performance. We’ll now examine how this stronger-than-expected revenue performance...

Live Oak Bancshares (LOB) has drawn investor attention after reporting 16.8% year on year revenue growth that topped expectations, while missing EPS and tangible book value estimates. This mix coincided with a sharp share price drop. See our latest analysis for Live Oak Bancshares. Beyond the immediate earnings reaction, Live Oak Bancshares’ share price at US$33.39 sits below its recent highs. It has a 7 day share price return of 4.05%, a 90 day share price return decline of 6.63%, while the...

In March 2026, Clarivate Plc released the Clarivate AI50, a data-driven benchmark ranking 50 leading organizations in high-impact artificial intelligence inventions, built on its Derwent World Patents Index and Strength Index analytics. The report highlights how AI innovation is clustering in a few countries and sectors, with government and academic institutions playing an outsized role in advancing foundational research and cross-border collaboration. We’ll now examine how this new AI50...

Ecovyst (ECVT) set fresh expectations for 2026, guiding full-year revenue to a range of $860 million to $940 million, tied to refinery utilization, mining demand, and regeneration services expansion. See our latest analysis for Ecovyst. The 18.2% 1 month share price return and 31.6% year to date share price return to $13.04 suggest building momentum, while the 134.1% 1 year total shareholder return highlights how recent expectations have reshaped sentiment around Ecovyst. If Ecovyst’s move...

COPT Defense Properties recently highlighted its dividend profile, with the annualized payout up 4.9% from last year and a current yield of 4.18%, alongside expectations for fiscal 2026 earnings of US$2.77 per share. This combination of steady dividend growth and projected earnings expansion underscores the REIT’s appeal for investors seeking income alongside operational stability in defense-focused real estate. Next, we’ll examine how this stronger dividend trajectory and earnings outlook...

Contract win puts fresh focus on US Foods Holding (USFD) US Foods Holding (USFD) just secured a maximum firm-fixed-price contract worth up to US$137.11 million to supply full-line food and beverage items to U.S. military services in Arizona through early 2027. The 322 day bridge agreement with the Defense Logistics Agency Troop Support adds government volume alongside the company’s broad commercial customer base and gives investors a defined revenue stream tied to Army, Navy, Air Force, and...

Teekay Tankers (NYSE:TNK) is back in focus as the closure of the Strait of Hormuz lifts spot tanker rates to multi decade highs. Management is also pointing to a potential record first quarter for 2026. See our latest analysis for Teekay Tankers. That backdrop of disrupted shipping routes has been reflected in the share price, with Teekay Tankers recording a 48.17% 3 month share price return and a 132.46% 1 year total shareholder return, suggesting momentum has been building rather than...

Event context and recent stock performance Sylvamo (SLVM) has been on investor radars after recent trading showed a mixed picture, with the share price at $42.73 and returns ranging from a 6.48% gain over the past week to a 10.85% decline over the past 3 months. See our latest analysis for Sylvamo. Stepping back, Sylvamo’s recent 6.48% 7 day share price return contrasts with a weaker 90 day share price return of 10.85% and a 1 year total shareholder return of 25.26%. This suggests momentum...

In Q1 2026, W. P. Carey completed about US$580 million of investments, including a US$210 million sale-leaseback of 14 premium auto dealerships in Western Canada leased to Go Auto, while refinancing a €215 million term loan with a larger CAD$347 million facility at lower cost. The combination of expanding its net lease portfolio and lowering borrowing costs signals a focused effort to support future cash flow resilience and dividend capacity. Next, we’ll examine how the CAD$347 million term...

If you are wondering whether BXP is pricing in too much pessimism or offering quiet value, its recent track record gives you plenty to think about. The stock closed at US$51.78, with a 0.7% move over the last week, a 2.2% decline over the last month, a 23.7% drop year to date, and a 10.1% decline over the past year, set against a 15.3% gain over three years and a 36.0% decline over five years. This mix of shorter term weakness and a stronger three year result has drawn fresh attention to...

In recent days, Starwood Property Trust announced that its board authorized up to US$400 million of common stock and convertible note repurchases over the next 12 months, alongside reporting stronger earnings and commentary pointing to improved dividend coverage. This combination of a sizable buyback and firmer dividend support signals management’s confidence in the balance sheet and the resilience of its diversified lending and net lease platform. Next, we’ll examine how the newly...

In recent days, Welltower Inc. reported a year-over-year gain in normalized FFO, raised its quarterly dividend by 10%, guided 2026 normalized FFO higher, and received credit rating upgrades from both S&P and Moody’s, underscoring stronger perceived financial resilience. An interesting angle for investors is that this mix of higher recurring payouts and improved credit quality highlights how Welltower’s operating platform and capital allocation approach are increasingly shaping its role in...

Event driven interest in NewAmsterdam Pharma NewAmsterdam Pharma (NasdaqGM:NAMS) is back on investors’ radar after an investor letter highlighted optimism around trial outcomes for its CETP inhibitor obicetrapib, supported by new data presentations at the ACC.26 cardiology conference. See our latest analysis for NewAmsterdam Pharma. NewAmsterdam Pharma’s recent presentations around obicetrapib, combined with the investor letter, come as the share price sits at US$32.99, with strong recent...

Georgia homeowners filed an arbitration complaint alleging D.R. Horton (NYSE:DHI) sold new homes with defective PEX plumbing that led to leaks and water damage. The filing claims D.R. Horton repaired some affected homes but did not alert all potentially impacted owners. Similar plumbing related complaints and legal actions are reported in multiple states, suggesting the issue may extend beyond Georgia. D.R. Horton is a major U.S. homebuilder focused on constructing and selling new...

ICON (ICLR) is back in focus after first quarter results showed earnings per share of $3.29, slightly below analyst expectations, while revenue of $2.01b aligned with consensus estimates. See our latest analysis for ICON. The latest 1 day share price return of 2.49% and 7 day gain of 11.86% come after a much steeper 90 day share price decline of 42.21%, leaving 1 year total shareholder return at a 25.72% loss. This indicates that recent momentum has been more positive despite a weaker longer...

Recent gains in Bicara Therapeutics (BCAX) stock have come alongside a series of fresh analyst updates, earnings results and clinical progress headlines that have sharpened attention on the company’s development pipeline. See our latest analysis for Bicara Therapeutics. The recent analyst upgrades and clinical updates have come alongside a clear build in momentum, with a 30 day share price return of 16.24% and a 1 year total shareholder return of 103.12% at a latest share price of $21.47. If...